These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

852 related items for PubMed ID: 17112773

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Utility of 2-[18F] fluoro-2-deoxy-D-glucose positron emission tomography and positron emission tomography/computed tomography imaging in the preoperative staging of head and neck squamous cell carcinoma.
    Roh JL, Yeo NK, Kim JS, Lee JH, Cho KJ, Choi SH, Nam SY, Kim SY.
    Oral Oncol; 2007 Oct; 43(9):887-93. PubMed ID: 17207656
    [Abstract] [Full Text] [Related]

  • 3. Positron emission tomography in the evaluation of stage III and IV head and neck cancer.
    Teknos TN, Rosenthal EL, Lee D, Taylor R, Marn CS.
    Head Neck; 2001 Dec; 23(12):1056-60. PubMed ID: 11774391
    [Abstract] [Full Text] [Related]

  • 4. FDG-PET and detection of distant metastases and simultaneous tumors in head and neck squamous cell carcinoma: a comparison with chest radiography and chest CT.
    Krabbe CA, Pruim J, van der Laan BF, Rödiger LA, Roodenburg JL.
    Oral Oncol; 2009 Mar; 45(3):234-40. PubMed ID: 18715818
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. 18fluorodeoxyglucose positron emission tomography to detect mediastinal or internal mammary metastases in breast cancer.
    Eubank WB, Mankoff DA, Takasugi J, Vesselle H, Eary JF, Shanley TJ, Gralow JR, Charlop A, Ellis GK, Lindsley KL, Austin-Seymour MM, Funkhouser CP, Livingston RB.
    J Clin Oncol; 2001 Aug 01; 19(15):3516-23. PubMed ID: 11481358
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [The application of 18F-fluorodeoxyglucose positron emission tomography in the diagnosis and staging of lung cancer].
    Xu HF, Liu Y, Zhang JH, Zhou RS, Zhou FH, Yuan MH.
    Zhonghua Jie He He Hu Xi Za Zhi; 2005 Feb 01; 28(2):108-11. PubMed ID: 15854393
    [Abstract] [Full Text] [Related]

  • 10. Clinical values for abnormal ¹⁸F-FDG uptake in the head and neck region of patients with head and neck squamous cell carcinoma.
    Lee HS, Kim JS, Roh JL, Choi SH, Nam SY, Kim SY.
    Eur J Radiol; 2014 Aug 01; 83(8):1455-60. PubMed ID: 24929443
    [Abstract] [Full Text] [Related]

  • 11. Post-treatment surveillance of head and neck cancer: pitfalls in the interpretation of FDG PET-CT/MRI.
    Meerwein CM, Queiroz M, Kollias S, Hüllner M, Veit-Haibach P, Huber GF.
    Swiss Med Wkly; 2015 Aug 01; 145():w14116. PubMed ID: 25701645
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Positron emission tomography with [18F]fluorodeoxyglucose improves staging and patient management in patients with head and neck squamous cell carcinoma: a multicenter prospective study.
    Lonneux M, Hamoir M, Reychler H, Maingon P, Duvillard C, Calais G, Bridji B, Digue L, Toubeau M, Grégoire V.
    J Clin Oncol; 2010 Mar 01; 28(7):1190-5. PubMed ID: 20124179
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 43.